Biotigen
Biotechnology Research • 
Warsaw, Masovian Voivodeship, Poland • 1-10 Employees
Company overview
| Headquarters | Twarda 18, Warszawa, Mazowieckie 00-105, PL |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
Key Contact at Biotigen
Dariusz Gappa
Owner at Biotigen
About Biotigen
We specialise in the research and development of Colostrum Bovinum. We supply COLOSTRUM of the highest quality to the global human and animal health markets, with certified production in Poland (EU). Using our extensive knowledge of the unique properties derived from colostrum, we want to make a significant difference to the health and quality of life of people and animals. We want to combine research, technology and knowledge to develop products that can prevent diseases, reduce their side effects or postpone the need for medication. We want to strengthen health with the motto: Natural help for a healthy gut.
Biotigen revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Biotigen has never raised funding before.
United States
Germany
United Kingdom
CanadaFrequently asked questions
4.8
40,000 users
